JY
TYRA icon

Jeff Yass’s Tyra Biosciences TYRA Stock Holding History

Jeff Yass’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,543
Closed -$514K – 14567
2026
Q1 		$595K Sell
15,543
-39,592
-72% -$1.28M ﹤0.01% 9218
2025
Q4 		$1.45M Buy
+55,135
New +$1.01M ﹤0.01% 6334
2025
Q3 		– Sell
-37,782
Closed -$362K – 13934
2025
Q2 		$362K Buy
37,782
+14,256
+61% +$135K ﹤0.01% 9916
2025
Q1 		$219K Buy
+23,526
New +$304K ﹤0.01% 10759
2023
Q4 		– Sell
-11,872
Closed -$154K – 13325
2023
Q3 		$163K Buy
+11,872
New +$176K ﹤0.01% 10456
2022
Q3 		– Sell
-16,663
Closed -$119K – 14151
2022
Q2 		$119K Buy
+16,663
New +$133K ﹤0.01% 11290

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jeff Yass's TYRA Position: Q2 2026 in Review

Jeff Yass sold out of Tyra Biosciences (TYRA) in Q2 2026, closing a stake of 15,543 shares — an estimated $514K sold.

Jeff Yass first reported a position in TYRA in Q2 2022 and held it in 6 quarters. The position peaked at $1.45M in Q4 2025. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Jeff Yass reported no remaining Tyra Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 15,543 Tyra Biosciences shares in Q2 2026, an estimated $514K.
  • Jeff Yass first reported a position in Tyra Biosciences in Q2 2022 and held it in 6 quarters.
  • Jeff Yass's Tyra Biosciences position peaked at $1.45M in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.